Prescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in September Potentially registrational trial is targeting enrollment of approximately 500 participants with ...

Organogenesis Holdings ($ORGO) announced an update on their ongoing clinical study. Study Overview Organogenesis Holdings (ORGO) is sponsoring a ...

Mission Hill Park in New Braunfels is under full construction and is expected to open in Spring 2026. The $12,155,000 project ...

Management stated, "Final data and conclusions from both cohorts [of the ASCEND trial] are anticipated for the first quarter of 2026." Nisco projected, "the company projects that available funds will ...

Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis (“UC”) reaches 1,003 of 1,224 participants, representing 82% of target enrollment. Enrollment completion ...

DUBAI, United Arab Emirates, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a developing decentralized lending protocol, has announced the successful completion of all Phase 1 roadmap ...

PRINCETON, N.J., Oct. 7, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...

HAIFA, Israel, Nov. 10, 2025 /PRNewswire/ -- Nurami Medical, a company developing next-generation regenerative solutions for soft tissue repair, has announced successful completion of Phase 1 of its ...

To ensure successful commissioning of the process plant, Western Potash Corp. (“Western”), a wholly owned subsidiary of the Company which owns the Project assets, has further enhanced its operation ...

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has given ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it earned a $10 million milestone payment from Janssen Pharmaceuticals, Inc., (Janssen) part of ...